Article
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
The New England Journal of Medicine
(2017)
Disciplines
Publication Date
October 19, 2017
DOI
10.1056/NEJMoa1615975
Citation Information
Philip Mease, Stephen Hall, Oliver FitzGerald, Désirée van der Heijde, et al.. "Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis." The New England Journal of Medicine Vol. 377 Iss. 16 (2017) p. 1537 - 1550 Available at: http://works.bepress.com/philip-mease/27/